Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | +0.29% | +19.93% | -17.10% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
Sales 2024 * | 59.49M 64.65M | Sales 2025 * | 79.05M 85.91M | Capitalization | 719M 781M |
---|---|---|---|---|---|
Net income 2024 * | -184M -200M | Net income 2025 * | -126M -137M | EV / Sales 2024 * | 10.1 x |
Net cash position 2024 * | 117M 127M | Net cash position 2025 * | 26.5M 28.8M | EV / Sales 2025 * | 8.76 x |
P/E ratio 2024 * |
-3.75
x | P/E ratio 2025 * |
-5.46
x | Employees | 1,086 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.65% |
Latest transcript on CureVac N.V.
1 day | +0.29% | ||
1 week | +19.93% | ||
Current month | +38.49% | ||
1 month | +35.80% | ||
3 months | +1.75% | ||
6 months | -37.57% | ||
Current year | -17.10% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 23-03-27 | |
Pierre Kemula
DFI | Director of Finance/CFO | 50 | 16-10-31 |
Malte Greune
COO | Chief Operating Officer | 59 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 19-05-31 |
Michael Brosnan
BRD | Director/Board Member | 69 | 23-06-18 |
Director/Board Member | 67 | 22-06-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.74% | 17 M€ | -.--% | - | |
0.06% | 2 M€ | -.--% | ||
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.49 | +0.29% | 2,390,095 |
24-05-16 | 3.48 | +9.09% | 1,350,635 |
24-05-15 | 3.19 | +2.90% | 515,225 |
24-05-14 | 3.1 | +4.38% | 342,719 |
24-05-13 | 2.97 | +2.06% | 228,232 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.10% | 782M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- CVAC Stock